Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
001540.KQ
Strong BuyFull HouseFLAGAhn-Gook Pharmaceutical Co., Ltd. · Healthcare · South Korea · $91M · Avg Vol: $660K/d
Ahn-Gook shows potential as a niche pharmaceutical player with strong momentum; however, the thesis is heavily reliant on quantitative valuation 'upside' from third-party tools rather than a clear articulation of a 'destination business' with shared scale economics. Monitoring for clearer proof of a durable moat.
COMPANY DESCRIPTION
Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.
FINANCIAL SUMMARY (KRW)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 205.4B | 233.7B | 271.1B | 306.9B | 14.3% | 347.4B |
| EPS (KRW) | 604.00 | 114.00 | 1,482 | 658.00 | 2.9% | 662.52 |
| Shares | 11.4M | 11.4M | 11.4M | 11.4M | 0.0% | 11.4M |
| Debt | 20.0B | 17.7B | 77.7B | 73.1B | 54.0% | 78.6B |
| Equity | 154.8B | 152.1B | 165.7B | 165.4B | 2.2% | — |
| Op CF | 1.8B | -1.3B | 4.9B | 45.7B | 194.5% | 39.6B |
| Inv CF | 6.4B | 17.2B | -75.4B | -12.4B | — | — |
| Fin CF | -3.7B | -5.1B | 57.2B | -10.2B | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 001540.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 001540.KQ | Ahn-Gook Pharmaceutical Co., Ltd.(you) | $91M | 100 | Strong Buy |
| 234080.KS | JW Lifescience Corporation | $128M | 93 | Strong Buy |
| 016580.KS | Whan In Pharm Co.,Ltd. | $137M | 94 | Strong Buy |
| 023910.KQ | Daihan Pharmaceutical Co.,Ltd. | $116M | 89 | Strong Buy |
| 096760.KS | JW Holdings Corporation | $209M | 100 | Strong Buy |
| 005500.KS | Samjin Pharmaceuticals Co., Ltd. | $170M | 93 | Strong Buy |
| 106190.KQ | High Tech Pharm Co., Ltd. | $86M | 81 | Strong Buy |
| 001630.KS | Chong Kun Dang Holdings Corp. | $136M | 86 | Strong Buy |
| 072020.KQ | Choong Ang Vaccine Laboratory Co., Ltd. | $63M | 82 | Strong Buy |
| 033270.KS | Korea United Pharm Inc. | $188M | 88 | Strong Buy |
Peer medians: ROE -0.3% · P/E 16.1x · Gross margin 43.0%